HK1091824A1 - Selectives synthesis of cf3-substituted pyrimidines - Google Patents

Selectives synthesis of cf3-substituted pyrimidines

Info

Publication number
HK1091824A1
HK1091824A1 HK06112349.7A HK06112349A HK1091824A1 HK 1091824 A1 HK1091824 A1 HK 1091824A1 HK 06112349 A HK06112349 A HK 06112349A HK 1091824 A1 HK1091824 A1 HK 1091824A1
Authority
HK
Hong Kong
Prior art keywords
selectives
synthesis
substituted pyrimidines
pyrimidines
substituted
Prior art date
Application number
HK06112349.7A
Other languages
English (en)
Inventor
John Charles Kath
Daniel Tyler Richter
Michael Joseph Luzzio
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HK1091824A1 publication Critical patent/HK1091824A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
HK06112349.7A 2003-09-05 2006-11-09 Selectives synthesis of cf3-substituted pyrimidines HK1091824A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50073303P 2003-09-05 2003-09-05
PCT/IB2004/002744 WO2005023780A1 (en) 2003-09-05 2004-08-24 Selective synthesis of cf3-substituted pyrimidines

Publications (1)

Publication Number Publication Date
HK1091824A1 true HK1091824A1 (en) 2007-01-26

Family

ID=34272990

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06112349.7A HK1091824A1 (en) 2003-09-05 2006-11-09 Selectives synthesis of cf3-substituted pyrimidines

Country Status (24)

Country Link
US (1) US7122670B2 (no)
EP (1) EP1663991B1 (no)
JP (1) JP4842816B2 (no)
KR (1) KR100694732B1 (no)
CN (1) CN100465164C (no)
AR (1) AR045557A1 (no)
BR (1) BRPI0414059B8 (no)
CA (1) CA2537373C (no)
CO (1) CO5650237A2 (no)
CY (1) CY1106370T1 (no)
DE (1) DE602004004287T2 (no)
DK (1) DK1663991T3 (no)
ES (1) ES2276344T3 (no)
HK (1) HK1091824A1 (no)
IL (1) IL173363A (no)
MX (1) MXPA06002552A (no)
NO (1) NO334383B1 (no)
NZ (1) NZ544969A (no)
PL (1) PL1663991T3 (no)
PT (1) PT1663991E (no)
RU (1) RU2315759C2 (no)
TW (1) TWI283667B (no)
WO (1) WO2005023780A1 (no)
ZA (1) ZA200600747B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20084357B (en) * 2002-12-20 2008-04-29 Pfizer Prod Inc Pyrimidine derivatives for the treatment of abnormal cell growth
US20060205945A1 (en) * 2004-05-14 2006-09-14 Pfizer Inc Pyrimidine derivatives for the treatment of abnormal cell growth
JP4778717B2 (ja) * 2005-03-25 2011-09-21 富士フイルム株式会社 複素環式化合物の製造方法
DE102007010801A1 (de) 2007-03-02 2008-09-04 Bayer Cropscience Ag Diaminopyrimidine als Fungizide
CN101678215B (zh) * 2007-04-18 2014-10-01 辉瑞产品公司 用于治疗异常细胞生长的磺酰胺衍生物
KR101294731B1 (ko) * 2007-06-04 2013-08-16 삼성디스플레이 주식회사 어레이 기판, 이를 갖는 표시패널 및 이의 제조방법
UY31714A (es) * 2008-03-20 2009-11-10 Boehringer Ingelheim Int Preparación selectiva de pirimidinas sustituidas
WO2009115583A1 (en) * 2008-03-20 2009-09-24 Boehringer Ingelheim International Gmbh Regioselective preparation of substituted pyrimidines
DE102009006643A1 (de) 2009-01-29 2010-08-05 Saltigo Gmbh Herstellung von halogenierten N-heteroaromatischen Polyhalogenderivaten
TW201100441A (en) 2009-06-01 2011-01-01 Osi Pharm Inc Amino pyrimidine anticancer compounds
US8933227B2 (en) 2009-08-14 2015-01-13 Boehringer Ingelheim International Gmbh Selective synthesis of functionalized pyrimidines
WO2011018517A1 (en) 2009-08-14 2011-02-17 Boehringer Ingelheim International Gmbh Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives
JP6000273B2 (ja) 2010-11-29 2016-09-28 オーエスアイ・ファーマシューティカルズ，エルエルシー 大環状キナーゼ阻害剤
UY33817A (es) 2010-12-21 2012-07-31 Boehringer Ingelheim Int ?nuevas oxindolpirimidinas bencílicas?.
EP2675793B1 (en) 2011-02-17 2018-08-08 Cancer Therapeutics Crc Pty Limited Fak inhibitors
CN103534240B (zh) 2011-02-17 2015-12-09 癌症疗法Crc私人有限公司 选择性fak抑制剂
WO2014126954A1 (en) 2013-02-13 2014-08-21 OSI Pharmaceuticals, LLC Regioselective synthesis of substituted pyrimidines
US9656970B2 (en) 2014-05-08 2017-05-23 Tosoh F-Tech, Inc. 5-(trifluoromethyl)pyrimidine derivatives and method for producing same
JP6391985B2 (ja) * 2014-05-16 2018-09-19 東ソー・ファインケム株式会社 ２−置換−４−（２，２，２−トリフルオロエトキシ）−５−（トリフルオロメチル）ピリミジン誘導体及びその製造方法
JP6391988B2 (ja) * 2014-05-21 2018-09-19 東ソー・ファインケム株式会社 ５−（トリフルオロメチル）ピリミジン誘導体の製造方法及び新規５−（トリフルオロメチル）ピリミジン誘導体
CN108440499A (zh) * 2018-03-22 2018-08-24 盐城师范学院 一种色瑞替尼及其关键中间体的制备方法
CN114213339B (zh) * 2021-12-20 2023-10-31 苏州康纯医药科技有限公司 一种表皮细胞生长因子受体突变抑制剂的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003030909A1 (en) * 2001-09-25 2003-04-17 Bayer Pharmaceuticals Corporation 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
ATE407678T1 (de) * 2001-10-17 2008-09-15 Boehringer Ingelheim Pharma Pyrimidinderivate, arzneimittel enthaltend diese verbindungen, deren verwendung und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
KR100694732B1 (ko) 2007-03-14
PL1663991T3 (pl) 2007-04-30
CN1845906A (zh) 2006-10-11
TWI283667B (en) 2007-07-11
CN100465164C (zh) 2009-03-04
BRPI0414059B8 (pt) 2021-05-25
CA2537373A1 (en) 2005-03-17
KR20060030918A (ko) 2006-04-11
BRPI0414059B1 (pt) 2018-11-06
DE602004004287T2 (de) 2007-06-21
ES2276344T3 (es) 2007-06-16
CA2537373C (en) 2009-10-20
NZ544969A (en) 2008-07-31
IL173363A (en) 2010-05-31
JP2007504211A (ja) 2007-03-01
AR045557A1 (es) 2005-11-02
BRPI0414059A (pt) 2006-10-24
TW200514773A (en) 2005-05-01
ZA200600747B (en) 2007-03-28
CY1106370T1 (el) 2011-10-12
CO5650237A2 (es) 2006-06-30
DK1663991T3 (da) 2007-04-10
AU2004270480A1 (en) 2005-03-17
JP4842816B2 (ja) 2011-12-21
US20050101620A1 (en) 2005-05-12
MXPA06002552A (es) 2006-06-20
EP1663991B1 (en) 2007-01-10
RU2315759C2 (ru) 2008-01-27
WO2005023780A1 (en) 2005-03-17
NO20061509L (no) 2006-04-03
IL173363A0 (en) 2006-06-11
NO334383B1 (no) 2014-02-24
DE602004004287D1 (de) 2007-02-22
US7122670B2 (en) 2006-10-17
RU2006106727A (ru) 2006-06-27
PT1663991E (pt) 2007-02-28
EP1663991A1 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
HK1091824A1 (en) Selectives synthesis of cf3-substituted pyrimidines
HK1173394A1 (zh) 二酮哌嗪的合成
AU2003213092A8 (en) Syntheses of quinazolinones
EP1778618A4 (en) SYNTHESIS OF TRIETHYLENETETRAMINES
ZA200605348B (en) Solid forms of anti-EGFR-antibodies
EP1546115A4 (en) SUBSTITUTED PYRIMIDINES
HK1085482A1 (en) Regioselective synthesis of cci-779
SI1476162T1 (sl) Nadzirana sinteza ziprasidona
PL378576A1 (pl) Wytwarzanie podstawionych chinazolin
EP1639121A4 (en) SYNTHESIS OF BETA-L-2-DESOXYNUCLEOSIDES
AU2003262794A8 (en) Total synthesis of heparin
GB0321091D0 (en) Synthesis
HK1097850A1 (en) Improved synthesis of 2-substituted adenosines
HK1095834A1 (en) Improved synthesis of 2-substituted adenosines
SI1663991T1 (sl) Selektivna sinteza CF3-substituiranih pirimidinov
IL178184A0 (en) Synthesis of pyrrole-2-carbonitriles
EG24122A (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
PL375437A1 (en) Synthesis of gatifloxacin
AU2003217354A8 (en) Synthesis of sulfamidates
GB0329319D0 (en) Synthesis
GB2422833B (en) Zaleplon synthesis
GB0328318D0 (en) Synthesis of spongosine
TW560584U (en) Improvement of screw
IL163778A0 (en) Processes for the synthesis of chloroadenosine andmethylthioadenosine
GB0225106D0 (en) Synthesis of 3 hydroxy-5 -steroids